Coziana Ciurtin

University College London - Centre for Adolescent Rheumatology Versus Arthritis

SCHOLARLY PAPERS

6

DOWNLOADS

271

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (6)

1.

Additional Analysis of the APPLE (Atherosclerosis Prevention in Paediatric Lupus Erythematosus) Trial Identifies Novel Determinants of Patient Heterogeneity and a Distinct Lipid Metabolomic Signature Associated with Atherosclerosis Progression

Number of pages: 24 Posted: 02 Feb 2023
University College London - Centre for Rheumatology Research, Scicross AB, Ohio State University (OSU) - Department of Pediatrics, Duke University - Duke Clinical Research Institute, Government of the United States of America - Lupus Genomics and Global Health Disparities Unit, University College London - Centre for Rheumatology Research, University College London - GOSH and Centre for Rheumatology Research and University College London - Centre for Adolescent Rheumatology Versus Arthritis
Downloads 84 (565,881)

Abstract:

Loading...

juvenile systemic lupus erythematosus, carotid intima-media thickness, atorvastatin, the APPLE trial, metabolomic signature

2.

Subclinical Atherosclerosis Risk Can Be Predicted in Females with Systemic Lupus Erythematosus (SLE) Using Metabolomic Signatures

Number of pages: 21 Posted: 08 Feb 2024
University College London, National and Kapodistrian University of Athens, University College London, University College London - Centre for Rheumatology Research, University College London, University College London, Vascular Noninvasive Diagnostic Centre, Imperial College London, University College London - Centre for Adolescent Rheumatology Versus Arthritis, University College London, University College London and University College London - GOSH and Centre for Rheumatology Research
Downloads 50 (736,440)
Citation 1

Abstract:

Loading...

Systemic lupus erythematosus, cardiovascular risk, metabolomics, atherosclerosis, machine learning

3.

Patients with Multiple Sclerosis Who Develop Immunogenicity to Interferon-Beta Have Distinct Transcriptomic and Proteomic Signatures Prior to Treatment Which are Associated with Disease Severity

Number of pages: 24 Posted: 15 Feb 2024
University College London, University College London, University College London, University College London, University College London - Centre for Adolescent Rheumatology Versus Arthritis, Charles University in Prague - Department of Neurology, Independent, University College London, Charles University in Prague, University College London and University College London - GOSH and Centre for Rheumatology Research
Downloads 43 (783,061)

Abstract:

Loading...

Multiple Sclerosis, Progression, Proteomics, Transcriptomics, Biomarkers, Immunogenicity, Anti-Drug Antibodies

4.

The Impact of Immunocompromise on Outcomes of COVID-19 in Children and Young People - A Systematic Review and Meta-Analysis

Number of pages: 22 Posted: 20 Jan 2023
University College London - Department of Adolescent Rheumatology, University College London - University College London Medical School, University College London - Centre for Adolescent Rheumatology Versus Arthritis and University College London - Centre for Adolescent Rheumatology Versus Arthritis
Downloads 41 (797,322)

Abstract:

Loading...

COVID-19, severe outcomes, immunosuppression, immunocompromise, children and young people, general population

5.

Simple Combined Clinical and Laboratory Markers of Hyperinflammation Predict Adverse Outcomes in Hospitalised Patients with Covid-19 and Suggest Dexamethasone Therapy May Not Be Suitable for All People

Number of pages: 21 Posted: 30 May 2024
University College London, University College London, University College London, University College London - University College London Hospitals NHS Foundation Trust, University College London, Newcastle Upon Tyne Hospitals NHS Foundation Trust, University College London - University College London Hospitals NHS Foundation Trust, Sheffield Teaching Hospitals NHS Foundation Trust, University College London - Centre for Adolescent Rheumatology Versus Arthritis, Government of the United Kingdom - Royal Wolverhampton NHS Trust, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Sheffield Teaching Hospitals NHS Foundation Trust, University of Southampton, University of Southampton - University Hospital Southampton NHS Foundation Trust, Department of Haematology, University College London - GOSH and Centre for Rheumatology Research and University College London
Downloads 29 (894,820)

Abstract:

Loading...

Hyper-inflammation, COVID-19, dexamethasone, diagnostic criteria

6.

Adalimumab Superior to Etanercept as First Line Biologic in ERA- a Drug Survival Single Centre Study Spanning 10 Years

Number of pages: 17 Posted: 03 Mar 2022
University College London, University College London - University College London Hospitals NHS Foundation Trust, affiliation not provided to SSRN, University College London - Centre for Adolescent Rheumatology Versus Arthritis, University College London - University College London Hospitals NHS Foundation Trust, University College London - University College London Hospitals NHS Foundation Trust, University College London, University College London, University College London - Centre for Adolescent Rheumatology Versus Arthritis and University College London - University College London Hospitals NHS Foundation Trust
Downloads 24 (941,995)

Abstract:

Loading...

Enthesitis-related arthritis, ERA, TNF inhibitor, adalimumab, etanercept, predictors, drug-survival